Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_assertion type Assertion NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_head.
- NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_assertion wasGeneratedBy ECO_0000203 NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_provenance.
- NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_assertion wasDerivedFrom befree-2016 NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_provenance.
- NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_assertion SIO_000772 17568789 NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_provenance.
- NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_assertion evidence source_evidence_literature NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_provenance.
- NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_assertion description "[To address disease heterogeneity in RA FLS cells, we examined the effects of clinical disease parameters (Health Assessment Questionnaire (HAQ) score, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF)) and drug therapies (methotrexate/prednisone) on RA FLS cell gene expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615218.RAYunIfwGSiu8WVRcYfbhL7tIh0XZHm060Ip7gJJKXSEw130_provenance.